Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
(NASDAQ: SEEL) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.28    EPS $ 
Volume 104,722       

(NASDAQ: SEEL) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High $ 
Open $1.28    52 Week Low $ 
Day High $1.28    P/E N/A 
Day Low $1.28    EPS $ 
Volume 104,722